ATC Group: N02AX Other opioids

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of N02AX in the ATC hierarchy

Level Code Title
1 N Nervous system
2 N02 Analgesics
3 N02A Opioids
4 N02AX Other opioids

Group N02AX contents

Code Title
N02AX01 Tilidine
N02AX02 Tramadol
N02AX03 Dezocine
N02AX05
N02AX06
N02AX07
N02AX51

Active ingredients in N02AX

Active Ingredient

Meptazinol is a centrally acting analgesic belonging to the hexahydroazepine series, which has demonstrated mixed agonist and antagonist activity at opioid receptors. It is used for the short term treatment of moderate pain.

Tapentadol is a strong analgesic with µ-agonistic opioid and additional noradrenaline reuptake inhibition properties. Tapentadol exerts its analgesic effects directly without a pharmacologically active metabolite.

Tilidine is a synthetic opioid painkiller, for the treatment of moderate to severe pain, both acute and chronic. Tilidine itself is only a weak opioid, but is rapidly metabolised in the liver and gut to its active metabolite nortilidine and then to bisnortilidine. It is the (1S,2R)-isomer (dextilidine)12 that is responsible for its analgesic activity. Nortilidine binds to opiate receptors in the central and peripheral nervous systems and suppresses pain perception and transmission.

Tramadol is a centrally acting opioid analgesic. It is a non selective pure agonist at μ-, δ- and κ-opioid receptors with a higher affinity for the μ-receptor. Other mechanisms which may contribute to its analgesic effect are inhibition of neuronal reuptake of noradrenaline and enhancement of serotonin release. Tramadol has an antitussive effect. In contrast to morphine, analgesic doses of tramadol over a wide range have no respiratory depressant effect.

Related product monographs

Document Type Information Source  
 DOLTREX Film-coated tablet MPI, Generic Health Products Regulatory Authority (ZA)
 MEPTID Film-coated tablet MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 MEPTID Solution for injection MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 NUCYNTA ER Film-coated tablet MPI, US: SPL/PLR FDA, National Drug Code (US)
 PALEXIA Film-coated tablet MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 PALEXIA Oral solution MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 PALEXIA SR Prolonged-release tablet MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 TRAMAL Capsule, Solution for injection, Tablet MPI, EU: SmPC Medicines and Medical Devices Safety Authority (NZ)
 ULTRAM Coated tablet MPI, US: SPL/PLR FDA, National Drug Code (US)
 ZYDOL Soluble tablet MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 ZYDOL Solution for injection or infusion MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 ZYTRAM XL Controlled release tablet MPI, CA: SPM Health Products and Food Branch (CA)